Skip to main content

Table 2 Correlates of currently receiving opioid agonist therapy (OAT) among people who inject drug in Iran in 2014

From: Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran

Variables   Crude OR (95% CI) P value Adjusted OR (95% CI) P value
Sex Male 1    
Female 2.17 (1.07, 4.37) 0.031   
Age at interview >35 1.26 (1.02, 1.55) 0.026   
≤35 1    
Marital status Single (never married) 1   1  
Ever married 1.35 (1.13, 1.61) 0.001 1.40 (1.12, 1.75) 0.004
Income ≤200 USD (6,000,000 Rials) 1    
>200 USD (6,000,000 Rials) 0.93 (0.75, 1.17) 0.569   
Education level High school and above 1    
Less than high school 1.11 (0.89, 1.38) 0.336   
History of incarceration (ever) Yes 1.43 (1.12, 1.84) 0.005 1.56 (1.16, 2.09) 0.003
No 1   1  
Substance use type in the past month** Only opioids 1   1  
Only non-opioids 0.55 (0.33, 0.92) 0.025 0.43 (0.26, 0.71) 0.001
Opioids and non-opioids 0.76 (0.57, 0.92) 0.072 0.66 (0.51, 0.86) 0.001
Self-perceived risk of HIV Yes 1.13 (0.92, 1.40) 0.223   
No 1    
HIV status Negative 1   1  
Positive 1.72 (1.15, 2.56) 0.009 1.63 (1.08, 2.50) 0.022
Source of recruitment Outreach 1    
Facility-based 0.89 (0.67, 1.19) 0.458   
  1. **Type of substance: non-opioids = Shishe, hashish/grass/cannabis, marijuana, ecstasy, cocaine, and methamphetamine/crystal; opioids = opium, opium sap, opium syrup, heroin, norchizak, tamchizak, buprenorphine, methadone, and crack